NZ613614A - Sphingoglycolipid compounds and uses - Google Patents
Sphingoglycolipid compounds and uses Download PDFInfo
- Publication number
- NZ613614A NZ613614A NZ61361412A NZ61361412A NZ613614A NZ 613614 A NZ613614 A NZ 613614A NZ 61361412 A NZ61361412 A NZ 61361412A NZ 61361412 A NZ61361412 A NZ 61361412A NZ 613614 A NZ613614 A NZ 613614A
- Authority
- NZ
- New Zealand
- Prior art keywords
- compounds
- sphingoglycolipid
- compositions
- conditions
- diseases
- Prior art date
Links
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ61361412A NZ613614A (en) | 2012-07-26 | 2012-07-26 | Sphingoglycolipid compounds and uses |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ61361412A NZ613614A (en) | 2012-07-26 | 2012-07-26 | Sphingoglycolipid compounds and uses |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ613614A true NZ613614A (en) | 2015-01-30 |
Family
ID=52464896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ61361412A NZ613614A (en) | 2012-07-26 | 2012-07-26 | Sphingoglycolipid compounds and uses |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ613614A (en) |
-
2012
- 2012-07-26 NZ NZ61361412A patent/NZ613614A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ629996A (en) | 2’- substituted carba-nucleoside analogs for antiviral treatment | |
WO2017059385A8 (en) | 11,13-modified saxitoxins for the treatment of pain | |
PH12015501385A1 (en) | Autotaxin inhibitors | |
MX343706B (en) | Novel heterocyclic derivatives. | |
IN2012DN02139A (en) | ||
NZ608116A (en) | Triazine-oxadiazoles | |
WO2013163190A8 (en) | Dna-pk inhibitors | |
TN2014000122A1 (en) | 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases | |
IN2015KN00492A (en) | ||
NZ707859A (en) | Inhibitors of sodium glucose cotransporter 1 | |
MX2013010898A (en) | Novel pyrimidine derivatives. | |
EA201491028A1 (en) | METHOD OF OBTAINING SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPIRIDINES | |
TN2014000112A1 (en) | Ep1 receptor ligands | |
MX2016007128A (en) | Ccr6 compounds. | |
MD4780C1 (en) | P-substituted asymmetric ureas and medical uses thereof | |
IN2014DN03010A (en) | ||
PH12015502703A1 (en) | Pharmaceutical compositions | |
NZ613614A (en) | Sphingoglycolipid compounds and uses | |
WO2009151495A3 (en) | Oxazole compounds, compositions and methods of use | |
WO2014102820A3 (en) | Rivaroxaban intermediate and preparation thereof | |
TN2013000441A1 (en) | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists | |
TN2013000089A1 (en) | Triazine-oxadiazoles | |
TN2013000327A1 (en) | Novel heterocyclic derivatives | |
TN2011000035A1 (en) | Organic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2018 BY CATALYST INTELLECTUAL PROPERTY Effective date: 20170623 |
|
ASS | Change of ownership |
Owner name: VICTORIA LINK LIMITED, NZ Effective date: 20180619 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2019 BY DR. STEFFEN SCHWARZ IPRIS AG Effective date: 20180716 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2020 BY DR. STEFFEN SCHWARZ IPRIS AG Effective date: 20190705 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2021 BY BIRGIT KNAACK Effective date: 20200714 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2022 BY CPA GLOBAL Effective date: 20210610 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2023 BY CPA GLOBAL Effective date: 20220609 |